Results 161 to 170 of about 164,277 (217)

Assessment of noninvasive parameters prior to diagnosis of pulmonary hypertension in patients with fibrotic interstitial lung disease. [PDF]

ERJ Open Res
Herbert S, Dimopoulos K, Jenkin I, Dawes TJW, Bax S, McCabe C, Nashat H, Mukherjee B, Rawal B, Wells AU, Renzoni E, George PM, Jenkins G, Wort SJ, Price LC.   +14 more
europepmc   +1 more source

Tiny carriers, big impact: How Fusobacterium nucleatum extracellular vesicles drive oral diseases and beyond

Interdisciplinary Medicine, EarlyView.
This review explores how Fusobacterium nucleatum extracellular vesicles drive local oral diseases and distal pathologies via sophisticated cross‐compartment cross talk. It highlights the transformative potential of these “tiny carriers” as next‐generation molecular intermediaries for advanced health monitoring and innovative bio‐interventions by ...
Rongyang Ma, Jiahui Huang, Yitong Chen, Haoxuan Wang, Hang Zou, Wanghong Zhao, Zilong Deng   +6 more
wiley   +1 more source

Rituximab for Early-Onset Juvenile Dermatomyositis Complicated by Interstitial Lung Disease. [PDF]

Case Rep Pediatr
Olszewska M, Mężyk E, Kurbiel M, Kmiecik W, Turowska-Heydel D, Sobczyk M, Żuber Z.   +6 more
europepmc   +1 more source

A compendium of extracellular vesicle biogenesis inhibitors: From bench to bedside

Interdisciplinary Medicine, EarlyView.
This review explores a decade of research on extracellular vesicles (EVs), detailing their biogenesis and roles in health and disease. It emphasizes EVs' relevance for potential medical applications covering various conditions such as cancer, neurodegeneration, inflammation, and infectious diseases, bridging experimental findings with clinical ...
Stefano Vecchione, Ana Talamillo, Juan M. Falcón‐Pérez   +2 more
wiley   +1 more source

Characterizing Race-Based Differences in Antisynthetase Syndrome Interstitial Lung Disease. [PDF]

Biomedicines
Pais F, Cook CM, Simeone S, Peterson JA, Akopyan K, Shamash M, Harden C, Hochhegger B, Reddy R, Gomez-Manjarres DC.   +9 more
europepmc   +1 more source

Beyond Tradition: An Integrated Toxicological, Ecological, and Public Health Perspective on Aristolochic Acids

Journal of Applied Toxicology, EarlyView.
ABSTRACT Aristolochia species have long been used in traditional medicine for their presumed anti‐inflammatory, analgesic and antimicrobial properties. However, extensive toxicological and epidemiological evidence now demonstrates that these plants contain aristolochic acids (AAs) I and II, highly potent nephrotoxic, genotoxic, and carcinogenic ...
Victor Ventura de Souza, Lara Rodrigues De Andrade, Tatiana da Silva Souza   +2 more
wiley   +1 more source

Familial interstitial lung disease: emerging insights into screening and genetic risk. [PDF]

Front Med (Lausanne)
Hernández Cristancho AP, Planas-Cerezales L, Molina-Molina M, Borie R, Wuyts WA, Jodar M, Sellares J, Hernandez-Gonzalez F.   +7 more
europepmc   +1 more source

Aspects of Quality of Life in Interstitial Lung Disease: Pilot Observational Cross-Sectional Study in a Single Center. [PDF]

JMIR Form Res
Rzepka-Wrona P, Trzaska Sobczak M, Barczyk A, Skoczyński S.   +3 more
europepmc   +1 more source

Sex-Dependent Integration of Symptoms and Functional Vulnerability in Interstitial Lung Disease: eurILDreg Study.

Respiration
Tello S, Windhorst AC, Mustafa H, Mahavadi P, Veit T, Behr J, Crestani B, Vancheri C, Molina MM, Guenther A, Krauss E.   +10 more
europepmc   +1 more source

Contemporary 0.55 T MRI to visualize interstitial lung disease - An exploratory study. [PDF]

Eur J Radiol Open
Bayerl N, Mathy CS, Bergmann C, Bäuerle T, Adams LC, Nagel AM, Distler JHW, Gerhalter T, Uder M, Heiss R, Ellmann S.   +10 more
europepmc   +1 more source